Alberta Health Services, Calgary
15
3
4
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
13%
2 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis
Role: lead
FIT-ATOMIC Exercise Feasibility Trial
Role: collaborator
CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma
Role: collaborator
Occipital Nerve Stimulation in Trigeminal Autonomic Cephalgias
Role: lead
Neuromodulation Parameter Efficacy
Role: lead
Early Integration of Palliative and Supportive Care in Cellular Therapy
Role: lead
Ferric Derisomaltose/Iron Isomaltoside and Outcomes in the Recovery of Gynecologic Oncology ERAS
Role: lead
Prophylactic LYMphatic Reconstruction (LYMbR) to Prevent Lymphedema After Node Dissection for Cutaneous Malignancies
Role: lead
Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery
Role: lead
Guided Occupational Therapist Cognitive Interventions in Critically Ill Patients
Role: lead
Connected Healthcare for Individuals Living at Home With Chronic Conditions
Role: lead
Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow
Role: lead
Primary Care Pathway for Childhood Asthma
Role: collaborator
Connecting Emergency Departments With Community Services to Prevent Mobility Losses in Pre-frail & Frail Seniors
Role: collaborator
E-Mental Health Adolescent Depression Program (LEAP)
Role: collaborator
All 15 trials loaded